The effect of cinnamon doses on blood serum glucose was studied in type 2 diabetic individuals for 60 days. Sixty type 2 diabetic individuals of both sexes and of age 48±6.5 years were divided into 6 groups; each group was having 10 individuals. Groups 1, 2 and 3 were assigned for 1g, 3g and 6g cinnamon doses/day respectively. Groups 4, 5 and 6 were assigned for 1g, 3g and 6g placebo doses/day respectively. The doses were equally distributed over the day. Cinnamon and placebo were given in the form of capsules with breakfast, lunch and dinner. The doses were given for 40 days and after 40 days; there was a 20 days blank period. Fasting blood samples were taken on days 0 (starting day of the experiment) 20, 40 and 60 and blood serums were separated. The blood serum glucose of both the cinnamon and placebo groups were determined. The mean fasting serum glucose levels for cinnamon doses on days 0, 20, 40 and 60 were 208.7, 189.1, 156.5 and 176.6 mg/dl for 1 g cinnamon dose/day; 206.2, 178.4, 170.3 and 177.8 mg/dl for 3 g cinnamon dose/day and 233.9, 183.2, 166.4 and 205.7 mg/dl for 6 g cinnamon dose/day respectively. The cinnamon doses significantly (P<0.05) reduced the mean fasting serum glucose levels while the placebo doses did not affect the serum glucose levels. In the light of this research, it is recommended that Type 2 diabetic individuals should use 1-3g cinnamon in their food preparations on regular basis. They can use cinnamon shakers for sprinkling of cinnamon powder on the curry in the plate. They can prepare cinnamon tea without sugar and can use it after meals. Also they can chew cinnamon bark after meals. This will keep their sugar level near to normal values.
Introduction
Diabetes mellitus is a chronic disorder of glucose metabolism resulting from dysfunction of pancreaticbeta cells and insulin resistance. It is still a serious health problem all over the world. Because the disease prevails in both genders and all age groups so, the general public has a concern about its control and treatment. Natural products like spices have been used for taste and flavor development in food preparations. Some spices have an additional benefit of having role i n carbohydrate metabolism (Khan et al., 1990 ) . Marles and Farnsworth (Marles and Fransworth, 1994) have reported that one-to two-thirds of the 1123 plants that affect blood glucose may be dangerous, and many of the phytochemicals are hypoglycemic due to metabolic or hepatic toxicity. However, medicinal plants have been used for diabetes safely and with reasonable success (Marles and Fransworth, 1994; Duke et al., 1998) . Botanical products can improve glucose metabolism and over all condition of persons with diabetes not only by hypoglycemic effect but also by improving lipid metabolism, antioxidant status, and capillary function (Broadhurst, 1997) . A number of medicinal/culinary herbs have been reported to yield hypoglycemic effects in subjects with diabetes. These include cinnamon, cloves, bay leaves, turmeric (Khan et al., 1990) , bitter melon (Srivastava et al., 1993; Raman and Lau, 1996) , gurmar (Basakaran et al., 1990; Bishayee and Chatterjee, 1994) , Korean ginseng (Sotaniemi et al., 1995) , onions and garlic (Koch and Lawson, 1996) , holy basil (Rai et al., 1997) , and flaxseed meal (Cunnane et al., 1993) . (Broadhurst et al.,2000) re-evaluated the extract o f cinnamon on insulin function in the insulin-dependent utilization of glucose using a rat epiddymal adipocyte assay . Cinnamon was the most bioactive product. The glucose oxidation enhancing bioactivity was lost from cinnamon by polyvinylpyrrolidone (PVP) treatment, indicating that the active phytochemical were likely to be phenolic in nature. They concluded that the extract of cinnamon had improved the glucose and insulin metabolism. Khan et al., 1990 isolated an unidentified factor from cinnamon and termed this factor as insulin potentiating factor (IPF). They demonstrated that IPF increased the activity of insulin 3 fold in glucose metabolism in rat epididymal fat cells. (Anderson et al., 2001 ) characterized this unidentified factor present i n cinnamon as methyl hydroxy chalcone polymers (MHCP). They reported that MHCP found in cinnamon increased insulin dependent glucose metabolism roughly 20 fold in vitro. They explained that MHCP made fat cells more responsive to insulin by activating the enzyme that causes insulin to bind to cells (insulindinner respectively. The individuals were told to take the receptor-kinase) and inhibiting the enzyme that blocks this process (insulin-receptor-phosphatase) leading to maximal phosphorylation of the insulin receptor, which is associated with increased insulin sensitivity. However, those studies were conducted in vitro. There is a general view that the results of animal studies may not be applied to human. Therefore, this study was designed to see the effect of cinnamon on blood glucose in Type 2 diabetic individuals.
Materials and Methods
Location, sample size and criteria for registration of the study: The study was conducted in the department of H uman Nutrition, NWFP Agricultural University Peshawar, Pakistan. Sixty type 2 diabetic individuals of both sexes and of age 40 years or older, who were residing in Peshawar city and its vicinity, were registered for the study. These diabetic individuals were registered at different times and at different locations, because diabetics were not available at one time. Only those diabetic subjects, who were not on insulin therapy, were not taking medicine for other health conditions and whose fasting blood glucose were in the range of 140-400mg/dl, were included in the study.
Preparation of cinnamon and placebo capsules:
Cinnamon and wheat flour were used for the preparation of cinnamon and placebo capsules. The required amount of cinnamon and wheat flour were purchased from the local market and ground finely. The ground cinnamon and wheat flour were given to Mehran Traders, Pharmaceutical Suppliers, Khalid Market, Charsadda Road, Peshawar for preparation of the capsules. Capsules were prepared and each capsule was having 500mg of cinnamon or wheat flour. Packages of 40 (1g or 2 capsules/day for 20 days), 120 (3g or 6 capsules/day for 20 days) and 240 (6g or 12 capsules/day for 20 days) of both the cinnamon and placebo capsules were prepared in plastic bags.
Protocol of the study:
The study was conducted for 60 days. The 60 type 2 diabetic individuals were divided into 6 groups. Each group was having 10 individuals. Groups 1, 2 and 3 were assigned to cinnamon and groups 4, 5 and 6 were assigned to placebo. The individuals were allowed to take their routine diet and usual diabetic medicine. Groups 1, 2 and 3 were given 1g, 3g and 6g cinnamon/day respectively for 40 days. From day 41 to 60, no dose of cinnamon was given. On similar pattern, 1g, 3g and 6g placebo/day were given to groups 4, 5 and 6 respectively for 40 days. The 1g doses of cinnamon and placebo were spread over the day as 0.5g ( 1 capsule) at the time of lunch and 0.5g (1 capsule) at the time of dinner. The 3g and 6g doses of cinnamon and placebo were spread over the day as 1g (2 capsules) and 2g (4 capsules) at the time of breakfast, lunch and capsules immediate after breakfast and meals. Collection of blood samples and biochemical analysis Approximately 5ml fasting blood samples were taken from each individual on day 0, 20, 40 and 60. Blood samples were transferred to sterilized centrifuge tubes and allowed for clotting at room temperature. The blood samples were centrifuged for 10 minutes in a centrifuge at 4000 rpm for serum separation. Serum samples were stored in freezer at 0 ºC for later analysis of glucose. These tests were done in the Main Laboratory, Hayat Abad Medical Complex by using auto analyzer (Express plus, Ciba corning USA).
Determination of Glucose:
Glucose was determined by the enzymatic calorimetric method of Trinder (Trinder, 1969) . Auto analyzer (Express plus, Ciba corning USA) and Elitech kit were used. In this method, the enzymatic reaction is in two steps. In the first step, glucose is oxidized to gluconic acid and hydrogen peroxide in the presence of glucose oxidase enzyme. In the second step, red quinone is formed in the presence o f peroxidase enzyme. The absorbance of this colored substance is taken and the concentration of glucose is calculated.
The enzymatic reactions are as follow:
Reagents: Reagent 1: Phosphate buffer, pH 7.40 100 mmol/l Phenol 10 mmol/l Reagent 2: Glucose oxidase > 10 000 U/l Peroxidase > 600 U/l 4-Amino antipyrine 270 µmol/l Sample: Serum free of hemolysis Procedure: The working reagent was prepared b y dissolving reagent 2 in reagent 1. This working reagent is stable for 1 month at 20-25 ºC and for 3 months at 2-8 ºC. The reagent reservoir was kept in the auto analyzer chamber. The wavelength was adjusted at 546 nm and the temperature was set at 37 ºC. Cuvette of 1cm light path was used. Before using the auto analyzer, it was calibrated and both normal and abnormal control ranges were given. If the sample reading falls between these two ranges and the auto analyzer shows the current calibration, then it is in a position to work properly and to give accurate results. 10 µl sample and 300 µl working reagent was sucked and mixed automatically and the analyzer gave the optical density (OD) after a short incubation period. Calculations: individuals of all the 3 groups were significantly (P<0.05) Factor = n / OD lower, when they used cinnamon doses for 40 days, n = Standard concentration than when they used cinnamon doses for 20 days, n = 100 mg/dL showing that longer use of cinnamon was more Glucose concentration = OD sample x factor beneficial than shorter use of cinnamon. The calculations were done automatically.
It should be pointed out that 40 days consumption of Statistical Analysis: Two-way Analysis of Variance and therapy and many diabetic individuals may not like such Randomized Complete Block Design was used for long treatment. Cinnamon is not a medicine but a spice statistical analysis (MSTAT-C).
and is used in food preparations for flavor and taste. So
Results and Discussion
Effect of cinnamon on blood glucose: The effect of various doses of cinnamon on the blood glucose levels of diabetic individual is given in Fig. 1 . The glucose values on day 0 in Table 1 indicate the fasting blood glucose of diabetic individuals before the start o f cinnamon capsules. So these glucose levels were control values for the study. On the starting day of the experiment (day 0), the mean fasting blood glucose levels of the diabetic individuals of the 3 groups, assigned for 1g, 3g and 6g cinnamon dose/day, were 208.7 mg/dl, 206.2 mg/dl and 233.9 mg/dl respectively. When the diabetic individuals o f these groups used 1g, 3g and 6g cinnamon doses/day for 20 days, their mean fasting blood glucose level dropped to 189.1 mg/dl, 178.4 mg/dl and 183.2 mg/dl respectively. The data demonstrated that cinnamon doses had reduced the mean fasting blood glucose level in all the 3 groups. However, this reduction in glucose levels was not statistically significant (P<0.05) from the mean fasting blood glucose values on day 0. This was perhaps due to the large variability in the blood glucose levels of individuals in each group (Table 1) . When the same individuals of the same groups used 1g, 3g and 6g cinnamon doses/day for another 20 days (total 40 days), their mean fasting blood glucose further dropped to 156.5 mg/dl, 170.3 mg/dl and 166.4 mg/dl respectively. Consumption of the various doses o f cinnamon for 40 days significantly (P <0.05) lowered the mean fasting blood glucose levels of diabetic individual of all the 3 groups of cinnamon as compared to the The mean fasting blood glucose levels of diabetic cinnamon for treatment of diabetes is really a lengthy it is a part of food and one would not be tired of its use. The hypoglycemic effect of cinnamon is an additional benefit of cinnamon and is particularly important for type 2 diabetic individuals. In the light of this research, it is recommended that diabetic individuals should use cinnamon in their food preparations on regular basis. They can use cinnamon shakers for sprinkling o f cinnamon powder on the curry in the plate. They can prepare cinnamon tea without sugar and can use it after meals. Also they can chew cinnamon bark after meals. This will keep their sugar level near to normal values. The mean fasting blood glucose levels of the diabetic individuals of all the 3 groups on day 60 (when they were not using cinnamon for the last 20 days) were 174.6 mg/dl, 177.8 mg/dl and 205.7 mg/dl respectively. The mean fasting blood glucose levels of the diabetic individuals of all the 3 groups on day 60 were significantly lower (P<0.05) than the mean fasting blood glucose levels of the diabetic individuals of all the 3 groups on day 0, but were non-significantly higher than the mean fasting blood glucose levels of the diabetic individuals of the 3 groups on days 20 and 40. This trend was justified as cinnamon was potentiating the function of i nsulin in carbohydrate metabolism and when cinnamon was not present, then insulin was not oxidizing glucose at the same rate as it was oxidizing it in the presence of cinnamon. Khan et al., 1990 has reported that an unidentified factor is present i n cinnamon that potentiates the action of insulin i n carbohydrate metabolism. They termed this factor as insulin potentiating factor (IPF). Broadhurst et al., 2000 reconfirmed the presence of this factor in cinnamon. This hypoglycemic effect of cinnamon may or may not be like other hypoglycemic drugs. The gradual increase in the mean fasting blood glucose levels of the individuals, who were not taking cinnamon doses for the last 20 days, indicated that cinnamon had lasting hypoglycemic effect in diabetic individuals. The cinnamon dose might have introduced some biochemical change at the cellular level and as a result the mean fasting blood glucose did not rise to the level where it was at the start of the experiment (day 0). We are not sure yet, but it seems that cinnamon might have brought some biochemical/physiological changes in the sites of resistance to insulin, transfer of glucose through cell membrane, enzyme system of carbohydrate metabolism and receptor sites. If the assumption of the authors, that the biochemical/physiological changes in the sites of resistance to insulin or other parameter is true, then a permanent cure for diabetes mellitus is present in cinnamon therapy. Symptoms of insulin resistance include a decreased stimulation of muscle glycogen synthesis, defects i n glycogen synthase activity, hexokinase activity and glucose uptake (Cline et al., 1999) . In addition, altered enzymatic activities, such as an increased phosphatase activity and/or seryl phosphorylation of the insulin receptor substrate by glycogen synthase kinase 3 (GSK-3), have also been shown to be involved in some cases of type 2 diabetes mellitus (Begum et al., 1991; Nadiv et al., 1994; Eldar and Krebs, 1997) . Dephosphorylation of the receptor $-subunit i s associated with the deactivation of its kinase activity and therefore is associated with insulin signal downregulation (King et al., 1991) . Jarvill-Taylor, et al., 2001 concluded from their study that methylehydroxy chalcone polymers (MHCP) was an effective mimetic of insulin. MHCP might be useful in the treatment of insulin resistance and in the study of the pathways leading to glucose utilization in cells. Cinnamon extracts have also been shown to improve insulin receptor function by activating insulin receptor kinase and inhibiting insulin receptor phosphatase, leading to increase insulin sensitivity (ImparlRadosevich et al., 1998) . Khan et al., 1990 isolated an insulin-potentiating factor (IPF) from cinnamon. This unidentified factor increased the activity of insulin 3 fold in glucose metabolism in rat epididymal rat fat cell. Anderson et al., 2001 characterized this unidentified factor present in cinnamon as methylehydroxy chalcone polymers (MHCP). They explained that MHCP made fat cells more responsive to insulin by activating the enzyme that causes insulin to bind to cells (insulin-receptorkinase) and inhibiting the enzyme that blocks this process (insulin-receptor-phosphatase) leading t o maximal phosphorylation of the insulin receptor, which is associated with increased insulin sensitivity.
To verify that the drop in the mean fasting blood glucose level was not due to psychological effect of the cinnamon capsules, a parallel placebo trial where placebo capsules were given to the groups of diabetic individuals in the pattern of cinnamon trial. Blood samples were collected and analyzed. The doses of placebo did not affect the glucose level (Fig. 2) . The effect of different cinnamon doses on the mean fasting blood glucose is given in Table 1 . There was no significant effect of cinnamon doses on the concentration of glucose in type 2 diabetic individuals. This indicated that small doses of cinnamon like 1 -3g/day were as good as 6g/day in reduction of glucose Jarvill-Taylor, K.J., R.A. Anderson and D.J. Graves, 2001 . level in diabetic individuals. The usual addition o f cinnamon as a spice to food preparations was sufficient for the additional benefit of reducing glucose level in diabetic individuals.
